SERPINA1 rs121912713: Understanding the Pi-Pittsburgh Variant
The rs121912713 variant, commonly known as Pi-Pittsburgh, is a rare genetic mutation in the SERPINA1 gene. It is uniquely associated with a bleeding disorder because it alters the function of the alpha-1 antitrypsin protein, causing it to inhibit blood clotting factors instead of its usual targets.
What each genotype means
Typical alpha-1 antitrypsin function
This genotype represents the common, functional version of the SERPINA1 gene. Individuals with this profile produce alpha-1 antitrypsin protein that effectively inhibits elastase to protect lung tissue, as expected in the general population.
This is the most common genotype found in the general population.
Pi-Pittsburgh variant carrier
This genotype includes the rare Pi-Pittsburgh mutation, which alters the alpha-1 antitrypsin protein so that it inhibits thrombin and factor XI instead of its usual targets. This change can lead to a bleeding disorder, as the protein's altered function interferes with normal blood clotting processes. Please consult with a hematologist or medical specialist to discuss the clinical implications of this specific variant.
This is an extremely rare genotype with no established frequency in the general population.
Pi-Pittsburgh homozygous state
This genotype indicates the presence of two copies of the Pi-Pittsburgh mutation. Research indicates this state is associated with a severe, potentially fatal bleeding diathesis due to the protein's potent anti-thrombin activity. Individuals with this profile should be under the care of a medical specialist to manage the associated bleeding risks.
This genotype is exceptionally rare and has been documented in clinical case reports of severe bleeding disorders.
What is the rs121912713 Variant?
The variant rs121912713 is a specific change in the DNA sequence of the SERPINA1 gene, located on chromosome 14. In scientific literature, this mutation is frequently referred to as the Pi-Pittsburgh allele or the Met358Arg mutation. This specific change involves the substitution of the amino acid methionine with arginine at position 358 of the alpha-1 antitrypsin protein. This position is critical because it serves as the active site of the protein. By changing this single building block, the variant fundamentally alters how the protein interacts with other molecules in the body. Unlike many other variants in this gene that lead to a simple deficiency of the protein, this specific mutation changes the protein's functional role entirely, turning it into a potent inhibitor of thrombin and factor XI, which are essential components of the human blood coagulation system.
The Role of the SERPINA1 Gene
The SERPINA1 gene provides the instructions for producing a protein called alpha-1 antitrypsin (AAT). Under normal conditions, AAT acts as a serine protease inhibitor, or 'serpin.' Its primary job is to protect tissues, particularly in the lungs, by neutralizing enzymes like neutrophil elastase that can break down connective tissue. When the gene functions normally, it ensures that these enzymes do not cause excessive damage to healthy organs. However, because the SERPINA1 gene is highly polymorphic, many different variants exist. While most well-known variants, such as the Z or S alleles, lead to a deficiency of the protein and subsequent lung or liver disease, the Pi-Pittsburgh variant is distinct. It does not just reduce the amount of protein; it changes the protein's target, effectively hijacking its normal protective function and redirecting it toward the blood clotting cascade.
Research and Clinical Associations
Research into rs121912713 has established a clear link between this variant and a rare, constitutional bleeding disorder. Because the mutated AAT protein acts as an inhibitor of thrombin and factor XI, it interferes with the body's ability to form stable blood clots. This leads to a clinical presentation characterized by a bleeding tendency of variable severity. The evidence for this association is considered strong within the context of rare genetic disorders, as the functional change in the protein directly explains the observed hemorrhagic symptoms. Unlike the more common AAT deficiency variants that are primarily associated with pulmonary emphysema or liver disease, the Pi-Pittsburgh mutation is specifically noted for its impact on coagulation. It is important to note that this is a rare condition, and clinical management is typically handled by specialists in hematology who can assess the specific bleeding risks associated with an individual's genetic profile.
Population Frequency and Prevalence
The rs121912713 variant is extremely rare in the general population. Unlike common genetic polymorphisms that are tracked in large-scale genomic databases to determine frequency across different ancestries, Pi-Pittsburgh is typically identified through clinical case studies rather than population-wide screening. There is no significant recorded frequency for this variant in major public databases like gnomAD, which suggests that it does not exist at a high frequency in any major ethnic group. Because it is so rare, it is not routinely included in standard genetic health panels. Its discovery is usually the result of targeted genetic testing performed after a patient presents with unexplained bleeding symptoms that do not respond to standard treatments. Consequently, the prevalence remains largely unknown, and it is considered a private or very rare mutation rather than a common population variant.
What You Can Do With This Information
If you have received information regarding this variant, it is essential to understand that this is a rare genetic finding that requires professional medical interpretation. You cannot use this information to self-diagnose or predict health outcomes without the guidance of a qualified healthcare provider or a genetic counselor. Because this variant is associated with a bleeding disorder, any clinical concerns regarding clotting or hemorrhage should be discussed directly with a hematologist. Do not make any changes to medications or treatment plans based on this information without consulting your clinician or pharmacist. Genetic testing results are complex, and a professional can help you understand the implications of your specific genotype, the potential for inheritance, and whether any specific medical monitoring is necessary for your health and well-being.
How common is this variant?
The rs121912713 variant is extremely rare and does not have a recorded frequency in major population databases, as it is typically identified in clinical settings rather than general population screenings.
Frequently asked questions
What is the Pi-Pittsburgh mutation?
Pi-Pittsburgh is a rare mutation in the SERPINA1 gene that changes the function of the alpha-1 antitrypsin protein. Instead of protecting the lungs, the mutated protein inhibits blood clotting factors, which can lead to a bleeding disorder.
Is rs121912713 the same as Alpha-1 Antitrypsin Deficiency?
While both involve the SERPINA1 gene, they are different. Common AAT deficiency is usually caused by variants like Z or S that lead to low protein levels, whereas Pi-Pittsburgh is a rare variant that changes the protein's function to affect blood clotting.
How is the Pi-Pittsburgh variant diagnosed?
Diagnosis is typically made through genetic testing and clinical evaluation by a specialist. It is usually investigated when a patient presents with unexplained bleeding symptoms.
Can I be tested for this variant?
Yes, it can be identified through targeted genetic sequencing. However, because it is very rare, it is not part of standard, broad-spectrum genetic health screenings.
What should I do if I have this variant?
You should consult with a hematologist or a genetic counselor to discuss the clinical implications. They can provide guidance on managing any potential bleeding risks and explain what this means for your health.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912713?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SERPINA1
The Pi*S allele of SERPINA1 that causes mild-to-moderate deficiency of alpha-1 antitrypsin.
The classical Pi*Z pathogenic allele in SERPINA1 leading to severe alpha-1 antitrypsin deficiency, lung emphysema, and liver disease.
Known as the S allele (p.Glu288Val), associated with mild alpha-1 antitrypsin deficiency when compounded with Z alleles.
The Z allele (E342K) of the SERPINA1 gene is the most common cause of severe alpha-1 antitrypsin deficiency, which can lead to lung and liver disease.
The classical 'Z' allele (p.Glu366Lys) of alpha-1 antitrypsin deficiency that predisposes individuals to chronic obstructive pulmonary disease and liver cirrhosis.
The Alpha-1-antitrypsin PI*I deficiency missense allele (Arg39Phe) predisposing carriers to reduced serum levels and pulmonary vulnerability.